The Spaniard gets another chance in Paris to consolidate himself in a Grand Slam
“I have a thorn in the side of last year,” admitted Paula Badosa, who stopped in the quarterfinals of the last edition of Roland Garros and who sees the great opportunity in the Paris Grand Slam to finally consolidate in these tournaments.
She’s not having her best moment, yes, because she hasn’t won three games in a row at Indian Wells since March and because the clay-court tour has been very thin for what she’s used to. He did not make it through the third round in Madrid or Rome and the best result was the semifinal of Charleston, a small tournament.
Roland Garros is his home, where he won the junior tournament in 2015 and started a rise in 2021 that culminated in the title in Indian Wells and number two in the world a few weeks ago. En route to the Roland Garros final, Badosa will make her debut against Fiona Ferro, facing Kaja Juvan in the second round, Veronika Kudermetova in third, Elena Rybakina in the round of 16 and Danielle Collins or Aryna Sabalenka in the quarter-finals. In the semi-final, which would mark her best result in a major, Iga Swiatek would expect to win 28 consecutive matches on the track, while Barbora Krejcikova would stay on for the final.
The other great Spanish option is that of a Garbiñe Muguruza who is going through a serious results crisis. He went to play in Rabat the week before Paris and didn’t make it past the round of 16, culminating in a clay tour in which he won just two games. Muguruza makes her debut in the tournament that crowned her in 2016 against Estonian Kaia Kanepi, whom she defeated in their only meeting in Australia in 2014.
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
